Sfoglia per AUTORE
LEDDA A
Collezione AO Cuneo
Items : 2
Carfilzomib with cyclophosphamide and dexamethasone or lenalidomide and dexamethasone plus autologous transplantation or carfilzomib plus lenalidomide and dexamethasone, followed by maintenance with carfilzomib plus lenalidomide or lenalidomide alone for patients with newly diagnosed multiple myeloma (FORTE): a randomised, open-label, phase 2 trial. in The Lancet. Oncology / Lancet Oncol. 2021 Dec;22(12):1705-1720. doi: 10.1016/S1470-2045(21)00535-0. Epub 2021 Nov 11.
2021
AO Cuneo
AOU Città della Salute di Torino
AO Cuneo
AOU Città della Salute di Torino
Petrucci MT; Gamberi B; Zambello R; Palmas A; de Fabritiis P; Aquino S; Giuliani N; Capra A; D'Agostino M; Patriarca F; Spadano A; Cea M; Ballanti S; Ledda A; Grasso M; Zamagni E; Offidani M; Galli M; Belotti A; Bertamini L; Rota-Scalabrini D; Musto P; Gay F; Corradini P; Cavo M; Boccadoro M;
Consensus Document of the Italian Association of Hospital Cardiologists (ANMCO), Italian Society of Cardiology (SIC), Italian Association of Interventional Cardiology (SICI-GISE) and Italian Society of Cardiac Surgery (SICCH): clinical approach to pharmacologic pre-treatment for patients undergoing myocardial revascularization procedures. in European heart journal supplements : journal of the European Society of Cardiology / Eur Heart J Suppl. 2017 May;19(Suppl D):D151-D162. doi: 10.1093/eurheartj/sux010. Epub 2017 May 2.
2017
AO Cuneo
AO Cuneo
Caporale R; Geraci G; Gulizia MM; Borzi M; Colivicchi F; Menozzi A; Musumeci G; Scherillo M; Ledda A; Tarantini G; Gerometta P; Casolo G; Formigli D; Romeo F; Di Bartolomeo R;